ExitValue.ai
Industry Guide8 min readApril 2026

How to Value an Urgent Care Franchise in 2026

Urgent care is one of the fastest-growing segments in healthcare, and franchised urgent care centers sit at an interesting intersection of healthcare delivery and franchise economics. I've worked on urgent care transactions ranging from single franchise locations to 20-center portfolios, and the valuation dynamics are meaningfully different from independent urgent care clinics.

The franchise model introduces variables that don't exist in independent operations — royalty obligations that reduce free cash flow, franchisor restrictions on how you run the business, but also brand value, operational support, and payer contracts that an independent would struggle to replicate. Getting the valuation right requires understanding all of these tradeoffs.

The Multiple Range: 4-7x EBITDA

Urgent care franchises typically trade at 4-7x EBITDA, with the wide range reflecting enormous variation in center performance, franchise system strength, and market dynamics. The median transaction I've seen in the franchise space is around 5.5x EBITDA for a single location and 6-7x for multi-unit operators.

These multiples are generally lower than what independent urgent care centers command in the open market. That might seem counterintuitive — shouldn't a brand name be worth more? The discount exists because of the royalty burden. A franchise paying 6-7% of revenue in royalties plus 2-3% into a marketing fund has structurally lower EBITDA margins than an identical independent center. The buyer is paying a multiple on a smaller earnings base.

Franchise Systems: Not All Created Equal

The specific franchise brand has a material impact on valuation, and buyers need to understand the differences.

American Family Care (AFC) is the largest urgent care franchise system in the US, with 300+ locations. AFC franchises tend to trade at the higher end of the range — 5.5-7x EBITDA— because the brand has strong payer recognition, established insurance contracts, and a track record of supporting multi-unit operators. AFC's emphasis on occupational health alongside walk-in urgent care creates diversified revenue streams that buyers value.

MedExpress (owned by Optum/UnitedHealth Group) operates a corporate model rather than a traditional franchise, but its locations occasionally trade when Optum divests underperforming markets. These transactions are more akin to corporate carve-outs and trade at 5-6x EBITDA, often with transition services agreements from Optum.

FastMed has grown aggressively in the Southeast and Southwest. FastMed locations trade at 4.5-6x EBITDA, with the range largely driven by payer mix and whether the center has on-site diagnostics (X-ray, labs) that generate ancillary revenue.

Newer or smaller franchise systems — and there are dozens — generally trade at the bottom of the range, 4-5x EBITDA, because they lack the brand recognition, payer contracts, and operational maturity that reduce buyer risk.

Franchise vs. Independent: The Real Economics

The franchise-vs-independent comparison is the central question for any buyer evaluating urgent care acquisitions. Here's how the economics actually shake out.

A typical urgent care center doing $2M in annual revenue will generate roughly $300-400K in EBITDA as an independent (15-20% margins) versus $200-300K as a franchise (10-15% margins after royalties and marketing fund contributions). The franchise pays less in absolute EBITDA, but arguably has lower operational risk.

The franchisor's value proposition includes: negotiated payer contracts with higher reimbursement rates, established EMR and billing systems, national marketing that drives patient volume, clinical protocols that reduce malpractice exposure, and ongoing operational support. Whether these benefits justify the 8-10% revenue haircut depends entirely on the specific market and operator.

In markets where urgent care is already saturated and brand recognition drives patient choice, the franchise premium makes sense. In underserved markets where any urgent care center will be busy regardless of brand, the royalty is pure drag on economics.

What Drives Value Up

Patient volume and visit trends. The single most important metric for any urgent care center is average daily patient visits. Centers seeing 40+ patients per dayare solidly profitable; those under 25 per day are struggling. Buyers want to see stable or growing visit volumes over 24-36 months. A center that peaked at 50 visits per day during COVID and has settled at 30 is a different story than one that's grown steadily from 25 to 40.

Occupational health contracts. Urgent care centers with employer contracts for drug testing, DOT physicals, workers' comp injury treatment, and pre-employment screenings have a built-in revenue floor. This B2B revenue is more predictable than walk-in volume, transfers cleanly to a new owner, and typically carries higher margins. Centers where occupational health represents 25-40% of revenue consistently sell at premium multiples.

Ancillary services. On-site X-ray, point-of-care labs, and IV therapy each add revenue per visit without proportionally increasing overhead. A center generating $85 revenue per visit from basic sick visits is worth less than one generating $140 per visit because it offers diagnostics and procedures on-site.

Payer mix. Commercial insurance reimburses urgent care at significantly higher rates than Medicare or Medicaid. A center with 70% commercial payer mix will have meaningfully better margins than one at 40%. Buyers scrutinize the payer mix closely because it directly impacts cash flow.

What Kills Value

Provider dependency. If the center's patient volume is built around a single physician or NP who patients specifically request, losing that provider means losing volume. Centers with rotating providers and strong operational branding (patients come for the brand, not the provider) are significantly less risky.

Lease problems. Urgent care centers require specific buildouts — exam rooms, X-ray suites, ADA compliance — that represent significant capital. A lease with less than 5 years remaining and no renewal options forces the buyer to either renegotiate under pressure or face the prospect of relocating a healthcare facility, which can cost $500K-$1M.

Franchise agreement restrictions. Some franchise agreements include transfer fees (often $25-50K), require franchisor approval of buyers, mandate facility upgrades at transfer, or restrict the sale price. Read the franchise disclosure document (FDD) and franchise agreement carefully — these provisions can reduce the effective sale price by 5-10%.

Regulatory and licensing risk. Urgent care centers must maintain state medical facility licenses, CLIA waivers for lab testing, and state radiology permits. Any lapse or deficiency in these areas is a major red flag that can delay or kill a transaction.

Multi-Unit Premiums

The biggest valuation jumps in urgent care come from multi-unit scale. A single franchise location at 5x EBITDA becomes a 5-location portfolio at 6-7x because the buyer — typically a healthcare-focused PE firm or a larger franchise operator — sees a platform with shared management, centralized billing, and negotiating leverage with payers.

If you operate multiple franchise locations, the path to maximum value is presenting them as an integrated platform rather than a collection of individual centers. That means consolidated financial reporting, unified management structure, and standardized operations across locations. The premium for "platform presentation" versus "portfolio of individual centers" can easily be a full turn of EBITDA.

The Bottom Line

Urgent care franchise valuations live in the tension between franchise economics and healthcare fundamentals. The brand and systems add value through reduced risk and operational support. The royalties and restrictions subtract value through reduced cash flow and limited flexibility. Understanding both sides of that equation — and how specific franchise systems, markets, and operational metrics shift the balance — is what separates informed buyers and sellers from those who rely on rules of thumb.

Want to see what your business is worth?

Institutional-quality estimates backed by 25,000+ real M&A transactions.

Get Your Valuation Estimate

Ready to See What Your Business Is Worth?

Start Your Valuation